Brian A. Ference
University of Cambridge(GB)MRC Clinical Trials Unit at UCL(GB)Fondazione Internazionale Menarini(IT)CSIRO Manufacturing(AU)
Publications by Year
Research Areas
Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins, Health Systems, Economic Evaluations, Quality of Life, Cancer, Lipids, and Metabolism, Genetic Associations and Epidemiology
Most-Cited Works
- → 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk(2019)8,575 cited
- → 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice(2021)5,933 cited
- → 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk(2019)4,829 cited
- → Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel(2017)3,675 cited
- → Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel(2020)1,462 cited
- → Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions